Comparative Analysis of Classification of Biotechnology Licensing Agreements


Abstract views: 22 / PDF downloads: 10

Authors

  • Sardor Mamanazarov Tashkent State University of Law

DOI:

https://doi.org/10.59022/ujldp.480

Keywords:

Biotechnology Licensing, Field-of-Use Restrictions, Patent Law, Technology Transfer

Abstract

This article presents a comprehensive classification system for licensing agreements in biotechnology, analyzing diverse license types including exclusive, non-exclusive, sole, and compulsory licenses, alongside specialized mechanisms such as conditional exclusivity, field-of-use restrictions, and geographic limitations. Drawing on international practices across the United States, the European Union, Japan, China, South Korea, and Uzbekistan, the study demonstrates that biotechnology’s unique characteristics necessitate sophisticated classification systems that exceed traditional industrial licensing frameworks. The research examines how different license types serve distinct commercial functions, analyzing the role of exclusive licenses in supporting substantial capital investments, the utility of non-exclusive licenses for platform technologies, and the importance of sole licenses in university-industry partnerships. The article proposes legislative reforms for Uzbekistan, introducing sole licensing recognition, differentiating registration requirements by license type, and establishing biotechnology-specific provisions addressing field-of-use restrictions, compulsory licensing, and conditional exclusivity mechanisms.

References

Covington & Burling LLP. (2024). Key Territory-Split Licensing Lessons for Life Sciences Companies. https://www.cov.com/-/media/files/corporate/publications/2024/11/key-territory-split-licensing-lessons-for-life-sciences-cos.pdf

Drozdoff, V., & Fairbairn, D. (2015). Licensing Biotech Intellectual Property in University–Industry Partnerships. Cold Spring Harbor Perspectives in Biology, 5(3), a021014. https://doi.org/10.1101/cshperspect.a021014

Freeman, J. W. (2007). Licensing Biotechnology Inventions. In A. Krattiger, R. T. Mahoney, L. Nelsen et al. (Eds.), Intellectual Property Management in Health and Agricultural Innovation: A Handbook of Best Practices. Oxford: MIHR; Davis: PIPRA. www.ipHandbook.org

Grieve, J., Tordoff, J., Reith, D., & Norris, P. (2005). Effect of the Pediatric Exclusivity Provision on Children’s Access to Medicines. British Journal of Clinical Pharmacology, 59(6), 730. https://doi.org/10.1111/j.1365-2125.2005.02327.x

Grootendorst, P. (2012). Canada’s Laws on Pharmaceutical Intellectual Property: The Case for Fundamental Reform. Canadian Medical Association Journal, 184(5), 543. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307559/

Miller, C. (2012, June 27). Patent Term Extensions and Regulatory Exclusivities for Pharmaceuticals in Asia and South America. Lexology. https://www.lexology.com/library/detail.aspx?g=0a295b70-e577-461b-99e5-48e0eeeac512

Moroğlu Arseven. (2021, September 1). Understanding the Doctrine of Exhaustion in the Context of Trademark Rights in Turkey. https://www.morogluarseven.com/news-and-publications/understanding-the-doctrine-of-exhaustion-in-the-context-of-trademark-rights-in-turkey/

Oqyulov, O. (2005). Intellektual mulk huquqi. I.M. Mo'minov nomidagi Falsafa va huquq instituti, Toshkent.

Pressman, L. (2006). The Licensing of DNA Patents by Large U.S. Academic Institutions. PLoS Biology. https://doi.org/10.1038/nbt0106-31

Recchia, G., & Jones, J. (2015, June 5). Pharmaceutical Patent Term Extension and Data Exclusivity in Australia, New Zealand, and Asia: Are You Missing Out? Lexology. https://www.lexology.com/library/detail.aspx?g=a78d9972-70b3-4707-9e4f-94192c6c21cb

Tan, J., Wang, A., & Gu, S. (2025, April 28). China Introduces a New Regulatory Data Protection and Exclusivity Mechanism. Arnold & Porter Advisory. https://www.arnoldporter.com/en/perspectives/advisories/2025/04/china-introduces-new-regulatory-data-protection-and-exclusivity

Teece, D. J. (1986). Profiting from Technological Innovation: Implications for Integration, Collaboration, Licensing, and Public Policy. Research Policy, 15, 285.

Thomas, J. R. (2016). Patents and Prescription Drug Importation. Congressional Research Service Report RL32400. https://sgp.fas.org/crs/misc/R44640.pdf

Published

2025-12-30

How to Cite

Mamanazarov, S. (2025). Comparative Analysis of Classification of Biotechnology Licensing Agreements . Uzbek Journal of Law and Digital Policy, 3(6), 105–124. https://doi.org/10.59022/ujldp.480

Issue

Section

Articles